Searched for
CLSA UPGRADE
Vedanta listings: 4 new Vedanta Group stocks debut on Dalal Street. What's ahead?Four Vedanta Group firms – Vedanta Aluminium, Vedanta Power, Vedanta Oil & Gas, and Vedanta Iron & Steel – debuted on BSE and NSE following...
Vedanta demerger: Which demerged stock should you buy after their market debut on June 15?Vedanta's mega demerger sees four new companies listing on June 15. Analysts suggest Vedanta Aluminium Metal as a strong buy due to capacit...
Will AI-led tech unwinding pause Rs 60,000 crore FII selloff in Indian IT stocks?Global markets are experiencing a tech selloff driven by AI fears, impacting Indian IT stocks with FIIs pulling Rs 60,000 crore. However, s...
Vedanta Resources looking to rejig $5.5 bn holdco debt in one goAnil Agarwal's Vedanta Resources Ltd is in talks with global banks to refinance its $5.25-5.5 billion debt. The company aims to raise $3.5-...
Vi shares double investments in 1 year. Here’s what analysts from Macquarie, JPMorgan, other global brokerages sayVodafone Idea shares have surged over 100% in a year. Analysts from Macquarie, JPMorgan, and other global brokerages offer mixed views. Whi...
Reliance share price target hiked to Rs 1,910: Why Goldman, CLSA, and Morgan Stanley are betting bigReliance Industries is gaining traction as Goldman Sachs raises its target price, with global brokerages predicting significant upside desp...
NHPC shares rally 10% in 2 days after CLSA upgrades to ‘high conviction outperform’NHPC Ltd's shares rise by 10% in 2 days following CLSA's upgrade to 'High Conviction Outperform' despite a slight reduction in target price...
CLSA upgrades DLF to high conviction outperform, stock rises 4%Global brokerage CLSA upgraded DLF to ‘High Conviction Outperform’ with a target of Rs 975, citing compelling valuation and strong growth p...
Healthcare stocks rally over 2% as CLSA upgrades Dr Lal Pathlabs and Aurobindo; DRL drops on downgradeHealthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperfo...
ONGC shares rally nearly 3%, continue winning streak following CLSA upgradeONGC Share Price: CLSA highlighted several key factors behind its bullish outlook for ONGC. The brokerage expects multiple volume and reali...
ONGC shares rally 4% as CLSA upgrades stock to 'high conviction buy,' sees 42% upsideShares of ONGC have increased by 22.4% in the last one year, however, have fallen by 8.1% and 8.5% in the last 6 months and 3 months respec...
CLSA upgrades BHEL stock on divestment expectationsCLSA believes BHEL has a lot to gain from a strategic partner.
CLSA upgrades M&M to buy, raises target priceCLSA has upgraded Mahindra & Mahindra to buy from outperform citing improving volume and earnings growth as well as attractive valuation.
Vedanta surges as CLSA upgrades stockCLSA sees prices of key commodities stabilising, with zinc prices on improving trend.
CLSA upgrades DLF to ‘buy’; sees over 30% upsideThe brokerage is of the view that there are several positive triggers for the company and has revised its target price to Rs 252.
Ranbaxy gains 4% on Lipitor production; CLSA upgrades to ‘outperform’CLSA upgraded the pharma major to ‘outperform’ from ‘sell’ earlier and has also increased its target price to Rs 475 from Rs 463 earlier.
CLSA upgrades Maruti Suzuki to 'Buy' on earnings outlookAfter three long years of gloom, Maruti Suzuki India Ltd's earnings outlook is finally improving and has upgraded the stock to 'BUY', said ...
CLSA upgrades rating for RIL to 'outperform', puts target price at Rs 850CLSA upgraded Reliance Industries to 'Outperform' on Friday and increased its 12-month target price for the stock to Rs 850.
- CLSA upgrades IDFC to ‘buy’
CLSA has upgraded the earnings of IDFC and has recommend a ‘Buy’ with a target of Rs 150 based on 1.5x FY14CL adjusted P/B.
- CLSA upgrades Infosys to outperform
India's second largest software exporter, Infosys, has been upgraded to Outperform by brokerage firm, CLSA. Analysts cited the company as a...